SIBN
SIBN
US8257041090
SI-BONE, Inc.
Loading chart...

Company Profile

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Latest News

Related stocks

CBLL
CBLL • United States
CeriBell, Inc.
23.63 USD
906.87M USD 1Y +89.1%
BVS
BVS • United States
Bioventus Inc.
13.07 USD
892.41M USD 1Y +87.7%
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
QDEL
QDEL • United States
QuidelOrtho Corporation
13.42 USD
920.28M USD 1Y -55.5%
VREX
VREX • United States
Varex Imaging Corporation
18.46 USD
783.88M USD 1Y +56.9%
PRCT
PRCT • United States
PROCEPT BioRobotics Corporation
18.4 USD
1.05B USD 1Y -48.5%
DCTH
DCTH • United States
Delcath Systems, Inc.
15.36 USD
532.97M USD 1Y +35.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
53.8% p.a.
Max Drawdown (5Y)
-59.8%
Sharpe Ratio (5Y)
-0.10
Beta Factor
0.66
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (53.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.8% in the extended horizon.
ende